Determining the resistance of species of Nocardia and other aerobic
Antimicrobials tested for Nocardia species and other aerobic actinomycete susceptibility include: amikacin, amoxicillin/clavulanic acid, ceftriaxone, ciprofloxacin, clarithromycin, doxycycline, imipenem, linezolid, minocycline, moxifloxacin, trimethoprim/sulfamethoxazole, and tobramycin.
For Rhodococcus equi, rifampin and vancomycin will also be tested.
Test Id | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
MIC | Susceptibility, MIC | No, (Bill Only) | No |
Test Id | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
SSNS | Susceptibility Nocardia species | No, (Bill Only) | Yes |
When this test is ordered, susceptibility for Nocardia species will be performed at an additional charge.
When the organism identification is Rhodococcus equi the additional reflex test will be performed at an additional charge for the additional antimicrobials vancomycin and rifampin.
Minimum Inhibitory Concentration (MIC)
Amikacin
Amikacin Sulfate (Amikin)
Amikin (Amikacin Sulfate)
Amoxicillin and Clavulanate Potassium (Augmentin)
Augmentin (Amoxicillin and Clavulanate Potassium)
Ciprofloxacin
Clarithromycin
Linezolid (Zyvox)
MIC (Minimum Inhibitory Concentration)
Minimum Inhibitory Concentration (MIC)
Minocycline
Moxifloxacin
Nocardia Susceptibilities
Sulfamethoxazole
Susceptibility Testing
Tobramycin
Zyvox (Linezolid)
Ceftriaxone
Trimethoprim/sulfamethoxazole
Doxycycline
Imipenem
When this test is ordered, susceptibility for Nocardia species will be performed at an additional charge.
When the organism identification is Rhodococcus equi the additional reflex test will be performed at an additional charge for the additional antimicrobials vancomycin and rifampin.
Varies
1. See Infectious Specimen Shipping Guidelines in Special Instructions.
2. Place specimen in a large infectious container (T146) and label as an etiologic agent/infectious substance.
Specimen source is required.
Question ID | Description | Answers |
---|---|---|
Q00M0037 | Specimen Source (Required) and Organism Identification (Required unless concurrent identification test is ordered) |
Specimen Type: Organism
Supplies: Infectious Container, Large (T146)
Container/Tube:
Preferred: Middlebrook 7H10 agar slant without antimicrobials
Acceptable: Sabouraud's dextrose agar slant or similar media without antimicrobials (eg, 7H11 agar slant, LJ, MGIT [7H9] broth media)
Specimen Volume: Isolate
Collection Instructions:
If not ordering electronically, complete, print, and send a Microbiology Test Request (T244) with the specimen.
Agar plate | Reject |
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Ambient (preferred) | ||
Refrigerated |
Determining the resistance of species of Nocardia and other aerobic
When this test is ordered, susceptibility for Nocardia species will be performed at an additional charge.
When the organism identification is Rhodococcus equi the additional reflex test will be performed at an additional charge for the additional antimicrobials vancomycin and rifampin.
Nocardia species and other aerobic actinomycetes can cause significant disease, often in immunocompromised patients. Clinical presentation can include, but is not limited to, pneumonia, skin abscess, bacteremia, brain abscess, eye infection, and joint infection.
The following are interpretive values for susceptibility testing of Nocardia species and other aerobic actinomycetes using a broth microdilution method.
Antimicrobial agent | Concentration range mcg/mL | Interpretations | ||
S | I | R | ||
Amikacin | 0.5-32 | < or =8 | - | > or =16 |
Amoxicillin/clavulanate | 2/1-128/64 | < or =8/4 | 16/8 | > or =32/16 |
Ceftriaxone | 1-64 | < or =8 | 16-32 | > or =64 |
Ciprofloxacin | 0.12-16 | < or =1 | 2 | > or =4 |
Clarithromycin | 0.03-16 | < or =2 | 4 | > or =8 |
Doxycycline | 0.12-16 | < or =1 | 2-4 | > or =8 |
Imipenem | 0.12-32 | < or =4 | 8 | > or =16 |
Linezolid | 0.5-16 | < or =8 | - | - |
Minocycline | 0.06-16 | < or =1 | 2-4 | > or =8 |
Moxifloxacin | 0.015-8 | < or =1 | 2 | > or =4 |
Tobramycin | 2-64 | < or =4 | 8 | > or =16 |
Trimethoprim/ Sulfamethoxazole | 0.06/1.19-8/152 | < or =2/38 | - | > or =4/76 |
For Rhodococcus equi only | | | | |
Rifampin | 0.5-2 | < or =1 | 2 | > or =4 |
Vancomycin | 0.5-16 | < or =2 | 4-8 | > or =16 |
Interpretive values for susceptibility testing of Nocardia species using a broth microdilution method are included in the report, as appropriate.
For Rhodococcus equi, the interpretive values for vancomycin and rifampin will also be included.
See Reference Values for additional information.
No significant cautionary statements
1. Duggai SD, Chugh TD: Nocardiosis: A neglected disease. [published online ahead of print, 2020 May 18]. Med Princ Pract. 2020;10.1159/000508717. doi:10.1159/000508717
A standardized inoculum made from a pure culture of aerobic actinomycete is prepared and inoculated into wells of a microtiter plate containing different concentrations of antimicrobial agents.
Growth at specified breakpoints is indicative of resistance.(Clinical and Laboratory Standards Institute (CLSI): Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes. 3rd ed. CLSI standard M24. CLSI; 2018; CLSI: Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes. CLSI supplement M62. CLSI; 2018)
Monday through Sunday
This test was developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.
87186
Test Id | Test Order Name | Order LOINC Value |
---|---|---|
MMLNS | Susc, Aerobic Actinomycetes | 29577-4 |
Result Id | Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
---|---|---|
MMLNS | Susc, Aerobic Actinomycetes | 29577-4 |